Literature DB >> 2873992

Metabolic fate of valproic acid in the rhesus monkey. Formation of a toxic metabolite, 2-n-propyl-4-pentenoic acid.

A W Rettenmeier, W P Gordon, K S Prickett, R H Levy, J S Lockard, K E Thummel, T A Baillie.   

Abstract

The metabolic fate of an iv bolus dose (13.5 mg kg-1) of valproic acid (VPA) was studied in adult male rhesus monkeys. Renal excretion proved to be the major route of elimination of the drug and a total of 17 metabolites, accounting collectively for some 82% of the administered dose, were identified in urine by GC-MS techniques. Many of these metabolites were present largely in the form of glucuronide conjugates, as was VPA itself. The principal pathways of VPA biotransformation were, in order of decreasing quantitative importance, ester glucuronide formation, omega-oxidation, beta-oxidation and (omega-1)-hydroxylation. In addition, three mono-unsaturated metabolites, identified as (E)-delta 2-, (E)-delta 3-, and delta 4-VPA, were detected in both plasma and urine. Quantitative analysis of these unsaturated VPA metabolites indicated that the delta 4 olefin, which is known to be a potent hepatotoxic agent, was the predominant isomer of the group.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2873992

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  6 in total

1.  Increases in metabolism of valproate and excretion of 6beta-hydroxycortisol in patients with traumatic brain injury.

Authors:  G D Anderson; A B Awan; C A Adams; N R Temkin; H R Winn
Journal:  Br J Clin Pharmacol       Date:  1998-02       Impact factor: 4.335

Review 2.  Valproate-associated hepatotoxicity and its biochemical mechanisms.

Authors:  M J Eadie; W D Hooper; R G Dickinson
Journal:  Med Toxicol Adverse Drug Exp       Date:  1988 Mar-Apr

3.  The effect of valproate on the metabolism of phenobarbital in the rat.

Authors:  G D Anderson; R H Levy
Journal:  Pharm Res       Date:  1992-12       Impact factor: 4.200

Review 4.  Differentiation between valproate-induced anticonvulsant effect, teratogenicity and hepatotoxicity. Aspects of species variation, pharmacokinetics, metabolism and implications of structural specificity for the development of alternative antiepileptic agents such as delta 2-valproate.

Authors:  H Nau; H Siemes
Journal:  Pharm Weekbl Sci       Date:  1992-06-19

5.  Placenta transfer and toxicokinetics of valproic Acid in pregnant cynomolgus monkeys.

Authors:  Eun Ju Jeong; Wook-Joon Yu; Choong-Yong Kim; Moon-Koo Chung
Journal:  Toxicol Res       Date:  2010-12

6.  Milk transfer and toxicokinetics of valproic Acid in lactating cynomolgus monkeys.

Authors:  Jong-Hwa Lee; Wook-Joon Yu; Eun Ju Jeong; Moon-Koo Chung
Journal:  Toxicol Res       Date:  2013-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.